Mice lacking Cryab displayed worse experimental autoimmune encephalomyelitis (EAE) and inflammation than wildtype littermates, while mice treated with recombinant Cryab showed a reduction in hyper-inflammatory response and demyelination effects seen in EAE [62]. Here, CRYAB is linked to experimental autoimmune encephalomyelitis.